These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Selective inhibitors and computer modelling of the active site of monoamine oxidase. Medvedev AE; Ivanov AS; Veselovsky AV Neurobiology (Bp); 2000; 8(2):201-14. PubMed ID: 11061215 [TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition. Morón JA; Campillo M; Perez V; Unzeta M; Pardo L J Med Chem; 2000 May; 43(9):1684-91. PubMed ID: 10794685 [TBL] [Abstract][Full Text] [Related]
5. The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding. Medvedev AE; Shvedov VI; Chulkova TM; Fedotova OA; Saederup E; Squires RF J Neural Transm Suppl; 1998; 52():337-42. PubMed ID: 9564636 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure. Hynson RM; Wouters J; Ramsay RR Biochem Pharmacol; 2003 Jun; 65(11):1867-74. PubMed ID: 12781338 [TBL] [Abstract][Full Text] [Related]
8. Inversion of selectivity of N-substituted propargylamine monoamine oxidase inhibitors following structural modifications to quaternary salts. Yu PH; Davis BA Int J Biochem Cell Biol; 1999 Dec; 31(12):1391-7. PubMed ID: 10641793 [TBL] [Abstract][Full Text] [Related]
11. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling. Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832 [TBL] [Abstract][Full Text] [Related]
12. Effects of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase-A and on GABAA receptors. Medvedev AE; Shvedov VI; Chulkova TM; Fedotova OA; Saederup E; Squires RF Neurochem Res; 1996 Dec; 21(12):1521-6. PubMed ID: 8953568 [TBL] [Abstract][Full Text] [Related]
13. Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase. Booysen HP; Moraal C; Terre'Blanche G; Petzer A; Bergh JJ; Petzer JP Bioorg Med Chem; 2011 Dec; 19(24):7507-18. PubMed ID: 22055712 [TBL] [Abstract][Full Text] [Related]
19. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833 [TBL] [Abstract][Full Text] [Related]
20. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models. Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]